Company Announcement: Bowmed Ibisqus joins the ACS Dobfar Group
Read more
Bowmed Ibisqus is a privately owned pharmaceutical company specialising in the supply of generic injectable medicines to both NHS hospitals and the private healthcare sector.
Operating from our base in rural North Wales, our UK team is committed to delivering sustainable cost efficiencies while maintaining uncompromising quality standards.
Bowmed Ibisqus is part of the ACS Dobfar Group, an international pharmaceutical organisation with extensive expertise in the development, manufacture and supply of injectable medicines and active pharmaceutical ingredients.
The ACS Group combines manufacturing excellence, regulatory knowledge and global supply capabilities to support healthcare providers and patients worldwide. Together, Bowmed Ibisqus and ACS Dobfar offer specialist UK market expertise with the strength, resources and long-term stability of an international pharmaceutical group.
